1. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria
- Author
-
Ayorinde Babatunde James, AP Okwuraiwe, Rahaman A. Ahmed, Sunday Omilabu, O.B. Salu, Fehintola A. Ige, Babatunde L. Salako, Gideon Liboro, Adesegun Adesesan, Leona Chika Okoli, Ebenezer O. Odewale, Judith O. Sokei, Oyewunmi Abosede Amuda, Chika K. Onwuamah, Joseph Ojonugwa Shaibu, O. S. Amoo, Rosemary A. Audu, Bola A O Oyefolu, and Dominic Achanya
- Subjects
RNA viruses ,Coronaviruses ,Sequence assembly ,Artificial Gene Amplification and Extension ,Protein Sequencing ,medicine.disease_cause ,Genome ,Polymerase Chain Reaction ,Sequencing techniques ,DNA sequencing ,Pathology and laboratory medicine ,Phylogeny ,Data Management ,Gel Electrophoresis ,Sanger sequencing ,Mutation ,Viral Genomics ,Multidisciplinary ,Reverse Transcriptase Polymerase Chain Reaction ,High-Throughput Nucleotide Sequencing ,Phylogenetic Analysis ,Genomics ,Amplicon ,Medical microbiology ,Phylogenetics ,GenBank ,Viruses ,symbols ,Medicine ,RNA, Viral ,SARS CoV 2 ,Pathogens ,Research Article ,Computer and Information Sciences ,SARS coronavirus ,Science ,Nigeria ,Computational biology ,Microbial Genomics ,Genome, Viral ,Biology ,Research and Analysis Methods ,Microbiology ,symbols.namesake ,Electrophoretic Techniques ,Virology ,medicine ,Genetics ,Humans ,Evolutionary Systematics ,Molecular Biology Techniques ,Molecular Biology ,Taxonomy ,Medicine and health sciences ,Evolutionary Biology ,Biology and life sciences ,Base Sequence ,SARS-CoV-2 ,Organisms ,Viral pathogens ,Dideoxy DNA sequencing ,COVID-19 ,Accession number (bioinformatics) ,Microbial pathogens ,Reference genome - Abstract
In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers’ instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.
- Published
- 2021